The report titled “Pulmonary Drug Delivery Devices Market- Growth, Future Prospects, and Competitive Analysis, 2023 – 2030” offers strategic insights into the overall pulmonary drug delivery devices market along with the market size and estimates for the duration 2020 to 2030. The said research study covers in-depth analysis of multiple market segments based on type of technology, application, and different geographies. Pulmonary drug delivery devices have been used for decades to deliver drugs for treatment of respiratory diseases. Pulmonary drug delivery pathway is considered as most efficient mode of drug delivery in respiratory diseases because lungs provide a huge surface area of alveoli with vast capillary network which provides an excellent absorbing surface for administration of drugs. Over the decade, rapid onset of action and higher efficiency was observed as the key driving factor for pulmonary delivery systems and also symptomatic relief in treatment of asthma and chronic obstructive pulmonary disease (COPD). Developments in device technology have also led to the development of more proficient delivery systems capable of providing large doses and micro particles into the lung.

For the purpose of this study, the global pulmonary drug delivery devices market is segmented on the basis of technology type into dry powder inhalers, metered dose inhalers, and nebulizers. Furthermore, dry powder inhalers are sub-segmented into unit-dose devices and multi-dose devices. Metered dose inhalers are of two types manually actuated pressurized inhalers, and breath-actuated pressurized inhaler. Nebulizers comprises jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. Market size estimates and forecast for these segments for the period 2020 to 2030 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2023 to 2030, considering 2021 as the base year.

The global pulmonary drug delivery devices market is also segmented on the basis of type of applications such as asthma, COPD, cystic fibrosis, diabetes, and others (allergic rhinitis, tuberculosis, among others). Market size estimates and forecasts for these segments for the period 2020 to 2030 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2023 to 2030, considering 2021 as the base year.

The geographical segmentation of pulmonary drug delivery devices market comprised regions such as North America, Europe, Asia-Pacific, Latin America & Middle East and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries. Market size and forecast for these segments during 2020 to 2030 and their CAGRs for the period 2023 to 2030 are provided in this report.

The pulmonary drug delivery devices market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are GlaxoSmithKline, Boehringer Ingelheim GmbH, 3M, AstraZeneca plc, Merck & Co., Inc., Novartis AG, Omron Corporation and Sunovion Pharmaceuticals Inc. among others.

In year 2021, metered dose inhalers accounted for the largest market share in pulmonary drug devices market due to key drivers rising prevalence of asthma and COPD across the globe, high patient convenience, the products and technology has penetrated in market over these years, and observed as the most preferred technology by physicians. During the forecast period 2023 – 2030, dry powder inhalers were anticipated as the fastest growing segment due to key driving factors such as short administration and preparation time, fewer irritant effects and control of inhaled dose, and API protection. A few major brands available in dry powder inhalers category are Spiriva, Atrovent, Foradil, Rotahaler, and FlowCaps among others.

In year 2021, Asthma was observed as the largest application segment in pulmonary drug delivery devices market due to key driving factors such as user-friendly designed device, most efficient and convenient way of drug delivery in asthma, and rising prevalence of asthma is fueling the overall growth of pulmonary drug delivery devices. Diabetes was observed as the fastest growing segment due to ongoing research and development for pulmonary delivery if insulin, a few product approvals delivering insulin through pulmonary pathway, high patient convenience due to non-invasive drug delivery and rising prevalence of diabetes globally.

In base year 2021, North America accounted for the largest market share in year 2021 due to key driving factors such as rising prevalence of asthma and COPD, high public awareness related to early diagnosis and treatment for respiratory disorders, developed healthcare infrastructure, and high accessibility to products with advanced technology. According to Centers for Disease Control and Prevention (CDC), in year 2020 number of adults had asthma were 18.4 million of which 6.2 million were children. During forecast period 2023 – 2030, Asia Pacific was observed as the fastest growing region due to key drivers such as rising prevalence of asthma and COPD, increasing air pollution due to rapid industrial growth, and high public awareness related to respiratory disease diagnosis. According to a report published by United Nations (UN), globally around seven million people a year die prematurely due to indoor and outdoor pollution with about 70 per cent of those deaths in the Asia Pacific.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Pulmonary Drug Delivery Devices market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Pulmonary Drug Delivery Devices market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Pulmonary Drug Delivery Devices market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Pulmonary Drug Delivery Devices market?
• Which is the largest regional market for Pulmonary Drug Delivery Devices market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Pulmonary Drug Delivery Devices market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Pulmonary Drug Delivery Devices market worldwide?